Oue, Kana
Oda, Aya
Shimizu, Yoshitaka
Takahashi, Tamayo
Kamio, Hisanobu
Sasaki, Utaka
Imamura, Serika
Imado, Eiji
Mukai, Akari
Doi, Mitsuru
Sakuma, Miyuki
Ono, Shigehiro
Aikawa, Tomonao
Yoshida, Mitsuhiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22K17184)
Article History
Received: 24 May 2023
Accepted: 12 October 2023
First Online: 21 October 2023
Declarations
:
: The protocol was approved by the Hiroshima University Certified Review Board (approval number: CRB2022-0001), and the ethical aspects of the trial were explained to the participants. Following the Declaration of Helsinki and its guidelines, informed consent was obtained from all patients before participation. This trial was registered in the Japan Registry of Clinical Trials (jRCTs061220052) on 30/8/2022.
: Not applicable.
: The authors declare no competing interests.